[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:ocular-histoplasmosis-syndrome":3},{"name":4,"total":5,"trials":6,"biomarkers":15,"states":16},"Ocular histoplasmosis syndrome",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07695298","A Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome",[11],"Phase 4","RECRUITING","2026-08-03T01:02:35.929011Z","2026-07-19T19:36:05.078400Z",[],[]]